Phase 1 Study to Evaluate the Safety and Immunogenicity of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, TSI-GSD 210, Lot 3-1-92, In Healthy Adults

NCT01159561 Phase 1 COMPLETED

This study is designed to determine the safety and immunogenicity of WEE Vaccine Lot number 3-1-92.

Details

Lead sponsor	U.S. Army Medical Research and Development Command
Phase	Phase 1
Status	COMPLETED
Enrolment	20
Start date	2010-02
Completion	2012-03

Conditions

• Virus

Interventions

• Western Equine Encephalitis Vaccine

Primary outcomes

• Subjects Reporting Adverse Events by Vaccination and Sex — 28 days following each vaccination

Countries

United States